Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RETRAP: resistance training plus prolonged-release fampridine in multiple sclerosis
2011-002959-34Phase 4Completed
- Sponsor
- Sygehus Sønderjylland
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in multiple sclerosis (MS) comparing Resistance training + Fampyra with Resistance training + placebo (2 arms). Primary endpoint: Lower-extremity muscle strength. Started Mar 2013; status: completed.
02
Drugs
dalfampridine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2011-002959-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002959-34.